Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

GH secretagogues under development at Merck & Co.

Nov. 24, 1997

Clinical trial demonstrates efficacy of NPS-R-568 in hyperparathyroidism

Nov. 24, 1997

Olpadronate associated with improvement in osteogenesis imperfecta

Nov. 24, 1997

Amylin, SIDDCO join forces for metabolic drug discovery

Nov. 21, 1997

Novel agent for insulin resistance, S-15261, evaluated in rat model

Nov. 21, 1997

Spotlight on selective estrogen receptor modulators

Nov. 21, 1997

Torii reveals antidiabetic thiazolidinediones

Nov. 21, 1997

Japanese researchers develop new animal model of obesity

Nov. 21, 1997

FDA advisory committee recommends approval of Prandin

Nov. 20, 1997

New ACAT inhibitor from Pierre Fabre

Nov. 20, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...